Ignite Creation Date:
2024-05-19 @ 5:33 PM
Last Modification Date:
2024-10-26 @ 3:29 PM
Study NCT ID:
NCT06417229
Status:
RECRUITING
Last Update Posted:
2024-06-27
First Post:
2024-05-13
Brief Title:
Study to Evaluate Safety Drug Levels Food and Relative Bioavailability of BMS-986365 in Healthy Adult Male Participants
Sponsor:
Celgene
Organization:
Celgene
Study Overview
Official Title:
A Phase 1 Two-part Open-label Single Ascending Dose Study to Evaluate Safety Tolerability and Pharmacokinetics of BMS-986365 Food and Proton Pump Inhibitor Effects and Relative Bioavailability of BMS-986365 Capsule Compared to Tablet Formulation in Healthy Adult Male Participants
Status:
RECRUITING
Status Verified Date:
2024-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to evaluate the safety tolerability drug levels food effects and relative bioavailability of BMS-986365 in healthy male participants
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None